Literature DB >> 12808109

p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.

Sonia Rocha1, Anthea M Martin, David W Meek, Neil D Perkins.   

Abstract

The p53 and NF-kappaB transcription factor families are important, multifunctional regulators of the cellular response to stress. Here we have investigated the regulatory mechanisms controlling p53-dependent cell cycle arrest and cross talk with NF-kappaB. Upon induction of p53 in H1299 or U-2 OS cells, we observed specific repression of cyclin D1 promoter activity, correlating with a decrease in cyclin D1 protein and mRNA levels. This repression was dependent on the proximal NF-kappaB binding site of the cyclin D1 promoter, which has been shown to bind the p52 NF-kappaB subunit. p53 inhibited the expression of Bcl-3 protein, a member of the IkappaB family that functions as a transcriptional coactivator for p52 NF-kappaB and also reduced p52/Bcl-3 complex levels. Concomitant with this, p53 induced a significant increase in the association of p52 and histone deacetylase 1 (HDAC1). Importantly, p53-mediated suppression of the cyclin D1 promoter was reversed by coexpression of Bcl-3 and inhibition of p52 or deacetylase activity. p53 therefore induces a transcriptional switch in which p52/Bcl-3 activator complexes are replaced by p52/HDAC1 repressor complexes, resulting in active repression of cyclin D1 transcription. These results reveal a unique mechanism by which p53 regulates NF-kappaB function and cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808109      PMCID: PMC164841          DOI: 10.1128/MCB.23.13.4713-4727.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

Review 1.  Activators and target genes of Rel/NF-kappaB transcription factors.

Authors:  H L Pahl
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

Review 2.  Control of apoptosis by Rel/NF-kappaB transcription factors.

Authors:  M Barkett; T D Gilmore
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

Review 3.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

4.  Down-regulation of nuclear factor kappaB is required for p53-dependent apoptosis in X-ray-irradiated mouse lymphoma cells and thymocytes.

Authors:  H Kawai; Y Yamada; M Tatsuka; O Niwa; K Yamamoto; F Suzuki
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

5.  Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kappaB activity.

Authors:  X H Pei; Y Nakanishi; K Takayama; F Bai; N Hara
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

6.  Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription.

Authors:  D Guardavaccaro; G Corrente; F Covone; L Micheli; I D'Agnano; G Starace; M Caruso; F Tirone
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis.

Authors:  C Albanese; M D'Amico; A T Reutens; M Fu; G Watanabe; R J Lee; R N Kitsis; B Henglein; M Avantaggiati; K Somasundaram; B Thimmapaya; R G Pestell
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

8.  Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells.

Authors:  J Shao; T Fujiwara; Y Kadowaki; T Fukazawa; T Waku; T Itoshima; T Yamatsuji; M Nishizaki; J A Roth; N Tanaka
Journal:  Oncogene       Date:  2000-02-10       Impact factor: 9.867

Review 9.  Aberrant rel/nfkb genes and activity in human cancer.

Authors:  B Rayet; C Gélinas
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

10.  Bcl3, an IkappaB protein, as a novel transcription coactivator of the retinoid X receptor.

Authors:  S Y Na; H S Choi; J W Kim; D S Na; J W Lee
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

View more
  93 in total

1.  Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation.

Authors:  Nathan Salomonis; Christopher R Schlieve; Laura Pereira; Christine Wahlquist; Alexandre Colas; Alexander C Zambon; Karen Vranizan; Matthew J Spindler; Alexander R Pico; Melissa S Cline; Tyson A Clark; Alan Williams; John E Blume; Eva Samal; Mark Mercola; Bradley J Merrill; Bruce R Conklin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

Review 2.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

3.  Association of RNF43 with cell cycle proteins involved in p53 pathway.

Authors:  Haiyang Xie; Chunyang Xing; Guoqiang Cao; Bajin Wei; Xiao Xu; Penghong Song; Leiming Chen; Hai Chen; Shengyong Yin; Lin Zhou; Shusen Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  Expression of the Bcl-3 proto-oncogene suppresses p53 activation.

Authors:  David Kashatus; Patricia Cogswell; Albert S Baldwin
Journal:  Genes Dev       Date:  2005-12-29       Impact factor: 11.361

5.  Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.

Authors:  Katie Schumm; Sonia Rocha; Jorge Caamano; Neil D Perkins
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

6.  CD8 T cells require Bcl-3 for maximal gamma interferon production upon secondary exposure to antigen.

Authors:  Paula M Chilton; Thomas C Mitchell
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 7.  NF-kappaB pathways in the immune system: control of the germinal center reaction.

Authors:  Christine A Goetz; Albert S Baldwin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.

Authors:  Mohammad Jamaluddin; Sanjeev Choudhary; Shaofei Wang; Antonella Casola; Ruksana Huda; Roberto P Garofalo; Sutapa Ray; Allan R Brasier
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 9.  A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase.

Authors:  Zhi-Chao Feng; Matthew Riopel; Alex Popell; Rennian Wang
Journal:  Diabetologia       Date:  2015-02-03       Impact factor: 10.122

10.  Zona occludens-2 inhibits cyclin D1 expression and cell proliferation and exhibits changes in localization along the cell cycle.

Authors:  Rocio Tapia; Miriam Huerta; Socorro Islas; Antonia Avila-Flores; Esther Lopez-Bayghen; Jörg Weiske; Otmar Huber; Lorenza González-Mariscal
Journal:  Mol Biol Cell       Date:  2008-12-03       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.